Search results
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 5 hours agoTerms of the settlements were not disclosed. The Post has sought comment from Pfizer. Zantac was...
Selma native talks at national cybersecurity event - The Selma Times‑Journal
The Selma Times-Journal· 6 hours agoGlaxoSmithKline assistant general counsel and Selma native Dondi West participated on a panel of...
Sen. Hassan slams GlaxoSmithKline over cost of asthma inhalers
New Hampshire Union Leader· 7 days agoPharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a...
Senator slams drugmaker for seeming to skirt pledge to cap inhaler cost
The Hill· 6 days agoDrug manufacturing giant GlaxoSmithKline (GSK) is subverting its pledge to lower the price of its...
Can a Risk Score Predict Kidney Injury After Cisplatin?
Medscape· 16 hours agoCisplatin is a preferred treatment for a wide range of cancers, including breast, head and neck,...
Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria
Medscape· 6 days agoRecent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK...
GSK Stock Today: Buying An August Covered Call Boosts Your Return By This Much
Investor's Business Daily· 2 days agoA covered call strategy is one way to slightly reduce the risk on a long stock position while also...
Clinical Trials: Focus on Quality Over Quantity of Life
Medscape· 7 days agoDr Maurie Markman discusses the need for pragmatic studies focusing on patient quality of life.
5 best blue chip stocks to invest in for sustainable gains in May - excluding Apple Inc. (AAPL) |...
Invezz· 6 days agoYesterday, the biggest company in the world in terms of market cap reported its latest earnings....
Competition from 'skinny label' generics saved medicare billions, according to report
Medical Xpress· 5 days agoAn analysis of 15 name-brand drugs and their "skinny label" generic counterparts found that...